{"id":"https://openalex.org/W1945841307","doi":"https://doi.org/10.1111/dom.12382","title":"Efficacy and safety of once\u2010weekly glucagon\u2010like peptide 1 receptor agonist albiglutide ( HARMONY 1 trial): 52\u2010week primary endpoint results from a randomized, double\u2010blind, placebo\u2010controlled trial in patients with type 2 diabetes mellitus not controlled on pioglitazone, with or without metformin","display_name":"Efficacy and safety of once\u2010weekly glucagon\u2010like peptide 1 receptor agonist albiglutide ( HARMONY 1 trial): 52\u2010week primary endpoint results from a randomized, double\u2010blind, placebo\u2010controlled trial in patients with type 2 diabetes mellitus not controlled on pioglitazone, with or without metformin","alternate_titles":[],"publication_year":2014,"publication_date":"2014-08-23","ids":{"openalex":"https://openalex.org/W1945841307","doi":"https://doi.org/10.1111/dom.12382","mag":"1945841307","pmid":"https://pubmed.ncbi.nlm.nih.gov/25155146"},"language":"en","primary_location":{"id":"doi:10.1111/dom.12382","doi":"https://doi.org/10.1111/dom.12382","is_oa":false,"landing_page_url":"https://doi.org/10.1111/dom.12382","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1945841307"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029406825","display_name":"Jane E.B. Reusch","orcid":"https://orcid.org/0000-0001-8620-1003","observed_orcids":["https://orcid.org/0000-0001-8620-1003"]},"institutions":[{"id":"https://openalex.org/I4210101549","display_name":"Denver VA Medical Center","ror":"https://ror.org/018hk2b97","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210101549","https://openalex.org/I4210113540","https://openalex.org/I4210148403"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"J. Reusch","raw_affiliation_strings":["Department of Endocrinology Denver Veterans Administration Medical Center Denver CO USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology Denver Veterans Administration Medical Center Denver CO USA","institution_ids":["https://openalex.org/I4210101549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113581999","display_name":"Murray W Stewart","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. W. Stewart","raw_affiliation_strings":["GlaxoSmithKline, Upper Merion, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Upper Merion, PA, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":null,"display_name":"C. M. Perkins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1296342797","display_name":"Pharmaceutical Product Development (United States)","ror":"https://ror.org/01sjx9496","country_code":"US","type":"company","lineage":["https://openalex.org/I1296342797"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. M. Perkins","raw_affiliation_strings":["PPD, Wilmington, NC USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PPD, Wilmington, NC USA","institution_ids":["https://openalex.org/I1296342797"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050151766","display_name":"Deborah T. Cirkel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"D. T. Cirkel","raw_affiliation_strings":["GlaxoSmithKline, Stevenage, UK;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Stevenage, UK;","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033331656","display_name":"J. Ye","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Ye","raw_affiliation_strings":["GlaxoSmithKline , Research Triangle Park , NC , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline , Research Triangle Park , NC , USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004846236","display_name":"Caroline Perry","orcid":"https://orcid.org/0000-0001-6387-319X","observed_orcids":["https://orcid.org/0000-0001-6387-319X"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. R. Perry","raw_affiliation_strings":["GlaxoSmithKline, Upper Merion, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Upper Merion, PA, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103574368","display_name":"Robert Reinhardt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. R. Reinhardt","raw_affiliation_strings":["GlaxoSmithKline, Upper Merion, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Upper Merion, PA, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005036709","display_name":"Bruce W. Bode","orcid":"https://orcid.org/0000-0002-9998-055X","observed_orcids":["https://orcid.org/0000-0002-9998-055X"]},"institutions":[{"id":"https://openalex.org/I4210107194","display_name":"Atlanta Diabetes Associates","ror":"https://ror.org/01j3vsz59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210107194"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B. W. Bode","raw_affiliation_strings":["Atlanta Diabetes Association Atlanta GA USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Atlanta Diabetes Association Atlanta GA USA","institution_ids":["https://openalex.org/I4210107194"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5029406825"],"corresponding_institution_ids":["https://openalex.org/I4210101549"],"apc_list":{"value":5380,"currency":"USD","value_usd":5380},"apc_paid":null,"fwci":11.9269,"has_fulltext":false,"cited_by_count":122,"citation_normalized_percentile":{"value":0.99148286,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"16","issue":"12","first_page":"1257","last_page":"1264"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/albiglutide","display_name":"albiglutide","score":0.9929999709129333},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.8960000276565552},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":0.9419999718666077},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.9509999752044678},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8870000243186951},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9350000023841858},{"id":"https://openalex.org/keywords/fasting-blood-glucose","display_name":"fasting blood glucose","score":0.7039999961853027},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.7929999828338623},{"id":"https://openalex.org/keywords/gastrointestinal-side-effects","display_name":"gastrointestinal adverse effects","score":0.9620000123977661},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5659999847412109},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.6439999938011169},{"id":"https://openalex.org/keywords/weight","display_name":"weight","score":0.37700000405311584}],"concepts":[{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.8081105351448059},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7862657904624939},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7761294841766357},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6529512405395508},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.5605796575546265},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5029799342155457},{"id":"https://openalex.org/C2778384471","wikidata":"https://www.wikidata.org/wiki/Q417765","display_name":"Pioglitazone","level":4,"score":0.4322342276573181},{"id":"https://openalex.org/C2779829264","wikidata":"https://www.wikidata.org/wiki/Q21011228","display_name":"Dulaglutide","level":5,"score":0.41030097007751465},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.41008684039115906},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.38610565662384033},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3783166706562042},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.34908515214920044},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.33972710371017456},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3390870988368988},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.32598137855529785},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.21732616424560547},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.141067236661911},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077205","descriptor_name":"Pioglitazone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D054795","descriptor_name":"Incretins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/dom.12382","doi":"https://doi.org/10.1111/dom.12382","is_oa":false,"landing_page_url":"https://doi.org/10.1111/dom.12382","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmid:25155146","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25155146","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W1976503602","https://openalex.org/W2007910256","https://openalex.org/W2050826565","https://openalex.org/W2066256335","https://openalex.org/W2090244618","https://openalex.org/W2097395605","https://openalex.org/W2105583547","https://openalex.org/W2109728760","https://openalex.org/W2118805427","https://openalex.org/W2128825255","https://openalex.org/W2159205789","https://openalex.org/W2160001758","https://openalex.org/W2172193326","https://openalex.org/W2190748907","https://openalex.org/W4253801677"],"related_works":["https://openalex.org/W2178377864","https://openalex.org/W2023695436","https://openalex.org/W2755926545","https://openalex.org/W2019513002","https://openalex.org/W2555729293","https://openalex.org/W4399880511","https://openalex.org/W1976503602","https://openalex.org/W2062098402","https://openalex.org/W2080002344"],"abstract_inverted_index":{"AIMS:":[0],"To":[1],"show":[2],"that":[3],"albiglutide,":[4],"a":[5,51,150],"glucagon-like":[6],"peptide-1":[7],"receptor":[8],"agonist,":[9],"is":[10,30],"an":[11,261],"effective":[12,270],"and":[13,140,165,194,216,234,238,243,247,251,271,275],"generally":[14,277],"safe":[15],"treatment":[16,65],"to":[17,62,91,172,263],"improve":[18],"glycaemic":[19],"control":[20],"in":[21,95,105,136,143],"patients":[22,49,155],"with":[23,33,66,113,116,160],"type":[24],"2":[25],"diabetes":[26],"mellitus":[27],"whose":[28],"hyperglycaemia":[29,169],"inadequately":[31],"controlled":[32],"pioglitazone":[34,54,188,264],"(with":[35,55,265],"or":[36,56,77,223,266],"without":[37,57,267],"metformin).":[38],"METHODS:":[39],"In":[40],"this":[41],"3-year,":[42],"randomized,":[43],"double-blind,":[44],"placebo-controlled":[45],"study,":[46],"310":[47],"adult":[48],"on":[50,192],"regimen":[52],"of":[53,154,168,208],"metformin)":[58,268],"were":[59,211,221],"randomly":[60],"assigned":[61],"receive":[63],"additional":[64],"albiglutide":[67,114,138,161,176,233],"[30":[68],"mg":[69,256],"subcutaneous":[70],"(s.c.)":[71],"once":[72,258],"weekly,":[73],"n":[74],"=":[75,81,201],"155]":[76],"matching":[78],"placebo":[79,117,145,182,235],"(n":[80,200],"155).":[82],"The":[83,100,225],"primary":[84],"efficacy":[85],"endpoint":[86],"was":[87,110,133,177,197,276],"change":[88,102],"from":[89,103,128],"baseline":[90,104,129],"week":[92,108,173],"52":[93,109,174],"(intention-to-treat)":[94],"glycated":[96],"haemoglobin":[97],"(HbA1c).":[98],"RESULTS:":[99],"model-adjusted":[101],"HbA1c":[106,158],"at":[107],"significantly":[111,151],"better":[112],"than":[115],"(-0.8%,":[118],"95%":[119],"confidence":[120],"interval":[121],"-1.0,":[122],"-0.6;":[123],"p":[124],"<":[125,148,163,184],"0.0001).":[126,185],"Change":[127],"fasting":[130],"plasma":[131],"glucose":[132,273],"-1.3":[134],"mmol/l":[135,142],"the":[137,144,157,166,206,214],"group":[139,146],"+0.4":[141],"(p":[147,162,183],"0.0001);":[149],"higher":[152],"percentage":[153],"reached":[156],"goals":[159],"0.0001),":[164],"rate":[167],"rescue":[170],"up":[171],"for":[175,181,229,232],"24.4":[178],"versus":[179],"47.7%":[180],"Albiglutide":[186,254],"plus":[187],"had":[189],"no":[190],"impact":[191],"weight,":[193],"severe":[195],"hypoglycaemia":[196],"observed":[198],"rarely":[199],"2).":[202],"With":[203],"few":[204],"exceptions,":[205],"results":[207],"safety":[209],"assessments":[210],"similar":[212],"between":[213],"groups,":[215],"most":[217],"adverse":[218],"events":[219],"(AEs)":[220],"mild":[222],"moderate.":[224],"52-week":[226],"incidence":[227],"rates":[228],"gastrointestinal":[230],"AEs":[231],"were:":[236],"31.3":[237],"29.8%,":[239],"respectively":[240],"(diarrhoea:":[241],"11.3":[242],"8.6%;":[244],"nausea:":[245],"10.7":[246],"11.3%;":[248],"vomiting:":[249],"4.0":[250],"4.0%).":[252],"CONCLUSIONS:":[253],"30":[255],"administered":[257],"weekly":[259],"as":[260],"add-on":[262],"provided":[269],"durable":[272],"lowering":[274],"well":[278],"tolerated.":[279]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1945841307","counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":21},{"year":2016,"cited_by_count":15},{"year":2015,"cited_by_count":20},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
